HIGHLIGHTS
- What: The authors aimed to evaluate whether the rs11706052 variant allele had an effect on the evolution of the graft function over the first post-transplant year in patients whose maintenance immunosuppression included MPA. The authors intended to contribute to the following question: in renal transplant recipients in whom MPA is a part of maintenance immunosuppression, is the IMPDH2 3757T > C genotype a factor that should be taken into account (e_g, should the MPA dosing be adjusted)? Patients Eligible were adults (age ≥ 16 years) providing informed consent for genotyping and the use of anonymized data for research . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.